 1.png "Image")
Meet the full Editorial Team behind Personal Care Insights.
Hugel cosmetics grow as botulinum toxin powers record H1 results
Hugel’s cosmetics and other businesses grew 31.7% in the first half of 2026, reaching net sales of ₩39 billion (US$27.6 million), with second-quarter sales for the segment up 32.8% to ₩19.8 billion...
Haut.AI cuts skin efficacy study setup from months to days with AI platform
Haut.AI has unveiled its Clinical Studies Software, a platform that scores skin efficacy studies’ results with AI rather than human panels. The AI-powered skin and hair analysis company says...
Reishi, chaga and tremella elevate mushroom-derived personal care
Demand for sustainable, functional, and natural ingredients is rising across the personal care industry. Customers and consumers want multifunctional ingredients, are renewably sourced, and survive...
Multifunctionality and texture reshape simple summer beauty routines
Summer brings more opportunities for outdoor activities, but with the added outside time comes increased skin exposure to the elements. For summer beauty routines, industry experts point out that the...
Daily use shift: Why SPF no longer defines sunscreen performance
The sun care category is undergoing a transformation. Once dominated by holiday-season demand and SPF-number competition, the sector is repositioning itself around daily protection, formulation...
NYSCC Suppliers’ Day 2026: Wacker to exhibit bio-based hair care and color cosmetics ingredients
At NYSCC Suppliers’ Day 2026 (May 19–20) in New York City, US, the Wacker Chemical Corporation is set to present ingredient technologies for hair care, skin care, sun care, and color cosmetics. The...
dsm-firmenich offloads Action Pin as strategic focus narrows to health and beauty
dsm-firmenich has sold its Action Pin business to AP Marensin, a consortium of investors created by FeBe Vermögensverwaltung, and backed by Econa and Ouest Croissance, a French private equity...
Givaudan Q1 sales exceed analyst expectations with Fragrance frontrunner
Givaudan has reported group sales of CHF 1.875 billion (US$2.40 billion) for the first quarter of 2026, representing a 2.8% increase on a like-for-like basis — ahead of analyst consensus expectations...
